SCM
SGYP

Stevens Capital Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Stevens Capital Management’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-14,967
Closed -$70K – 1176
2017
Q1 		$70K Buy
+14,967
New +$86.8K ﹤0.01% 826
2016
Q1 		– Sell
-40,047
Closed -$227K – 1208
2015
Q4 		$227K Buy
40,047
+16,072
+67% +$98K 0.01% 768
2015
Q3 		$127K Buy
+23,975
New +$186K 0.01% 882
2014
Q1 		– Sell
-28,661
Closed -$159K – 1427
2013
Q4 		$159K Sell
28,661
-20,134
-41% -$86.8K ﹤0.01% 936
2013
Q3 		$220K Buy
48,795
+33,597
+221% +$151K 0.01% 878
2013
Q2 		$65K Buy
+15,198
New +$76.4K ﹤0.01% 877

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return